Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

11.3K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.3K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

7.2K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.2K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

11.3K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.6K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.6K
Cancer Vaccines01:30

Cancer Vaccines

251
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
251
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

8.4K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.4K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Mass spectrometry-based mapping of conformational epitopes on SARS-CoV-2 antigens targeted by monoclonal antibodies.

International journal of biological macromolecules·2026
Same author

Molecular Epidemiology to Decipher the Transmission Networks of MPOX in an Outbreak Scenario: Applications in Thailand during the 2023 Global Health Emergency.

The Journal of infectious diseases·2026
Same author

Authors reply: "Development and internal validation of machine learning in predicting prognosis of acute kidney injury patients in resource-limited setting".

Journal of critical care·2026
Same author

The Phase Ib IMPACT Trial of Intramuscular Personalized Neoantigen Synthetic Long Peptide Vaccines in Patients with Advanced Melanoma and Renal Cell Carcinoma.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

MUC1-targeted CAR-T cell secreted anti-PD-1 IgG antibody enhances antitumor activity in Cholangiocarcinoma.

Scientific reports·2026
Same author

Correction: Analytical validation of a metagenomic next-generation diagnostic platform for urinary tract infection in a Thai tertiary hospital setting: a BI-Biotia UTI cohort study.

Frontiers in cellular and infection microbiology·2026

相关实验视频

Updated: May 12, 2025

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

11.7K

来自泛癌转录异型的潜在共享新抗原.

Jirapat Techachakrit1,2, Aijaz Ahmad Malik1, Trairak Pisitkun2,3

  • 1Center of Excellence in Computational Molecular Biology, Faculty of Medicine, Chulalongkorn University, Bangkok, 10330, Thailand.

Scientific reports
|May 7, 2025
PubMed
概括

癌症同位素切换创造了共享的新抗原,为广泛的免疫疗法提供了一个有希望的途径,适用于许多患者,减少了对个性化癌症治疗的需求.

关键词:
免疫治疗的目标是免疫疗法.异形切换的切换方式分享的胰腺癌新抗原.

更多相关视频

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.5K
Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles
09:28

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Published on: November 17, 2018

11.4K

相关实验视频

Last Updated: May 12, 2025

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

11.7K
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.5K
Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles
09:28

Enrich and Expand Rare Antigen-specific T Cells with Magnetic Nanoparticles

Published on: November 17, 2018

11.4K

科学领域:

  • 在瘤学瘤学.
  • 免疫学 免疫学 免疫学
  • 基因组学就是基因组学.

背景情况:

  • 异形切换在癌症中很常见,可以产生独特的癌症特异性蛋白质.
  • 这些蛋白质可以作为新抗原,可能引起免疫反应.
  • 目前的免疫疗法通常依赖于个性化的新抗原识别.

研究的目的:

  • 在多种癌症类型中识别常见的与癌症相关的异型切换事件.
  • 调查这些事件的潜力,作为广泛适用于免疫治疗的新抗原的来源.
  • 评估由异型切换产生的新抗原的免疫性.

主要方法:

  • 整合了五个大规模的转录基因数据集 (>19,500个样本,29种癌症类型).
  • 鉴定了与癌症相关的异形切换事件.
  • 在蛋白质组数据集中确认了含有新抗原的.
  • 进行了分子动力学模拟,以预测新抗原-HLA结合亲和力.

主要成果:

  • 在多种癌症类型中确定了常见的异形切换事件,其中一些涉及瘤基因.
  • 在蛋白质组数据中确认了这些事件中含有新抗原的的存在.
  • 证明了新抗原与人类白细胞抗原 (HLA) 复合物的预测结合亲和力.
  • 提供了强有力的证据,证明异形切换是可操作的新抗原的来源.

结论:

  • 与癌症相关的异形切换是可操作的新抗原的重要来源.
  • 这些新抗原有可能触发免疫反应.
  • 异形切换事件可以用于各种癌症类型的广泛,非个性化免疫治疗策略.